Therapeutic Innovation Australia
TIA invests in translational research infrastructure to enable seamless access to expertise and services vital to translate research discoveries into human health impacts. Our investment in people and capital lowers the financial bar to access expertise for all translational researchers, including academics, clinicians, medical research institutes and small-medium enterprises. Through initiatives such as the Pipeline Accelerator and Technical Feasibility Assessment voucher schemes, we also provi
Basic Information
- Category: organization
- Website: https://therapeuticinnovation.com.au
Documented Facts
- Email: info@therapeuticinnovation.com.au (No linked source recorded for this statement.)
Evidence and Sources
Citation Guidance
Explore organization profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Therapeutic Innovation Australia.
- Canonical profile: https://brandsource.ai/brands/therapeutic-innovation-australia
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/therapeutic-innovation-australia/json-ld
- Citation profile API: https://brandsource.ai/api/brands/therapeutic-innovation-australia/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (77/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
TIA invests in translational research infrastructure to enable seamless access to expertise and services vital to translate research discoveries into human health impacts. Our investment in people and capital lowers the financial bar to access expertise for all translational researchers, including academics, clinicians, medical research institutes and small-medium enterprises. Through initiatives such as the Pipeline Accelerator and Technical Feasibility Assessment voucher schemes, we also provi
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.